Clinical Trial Update: Durability of Hypertonic Saline for Enhancing Mucociliary Clearance in Cystic Fibrosis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update examines how durable the benefits of inhaled hypertonic saline are for improving mucociliary clearance in cystic fibrosis. Results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Hypertonic saline (inhalation, 7%) (sodium chloride 7% inhalation)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED | Results posted: 2012-08-21